Commenting on the appointment, Stefan Gebauer, head of Business Unit Preanalytics, said: “We are very pleased to have won Ana-Maria Šimundić as director of the newly created Global Medical & Clinical Affairs department. With her on board, we now have one of the world’s leading experts from the field of preanalytics in our team. She is the ideal choice for us to ensure that we can continue to offer innovative and efficient solutions that will help our customers overcome the daily challenges in the preanalytical laboratory environment.”
Šimundić is a well-known key opinion leader in Europe in laboratory diagnostics and preanalytics. She not only brings a wealth of expertise and experience in the medical and clinical field, but is also very well networked. From 2020 to 2021, she was president of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM), and now she is a member of the International Federation of Clinical Chemistry (IFCC) Executive Board as an EFLM representative and a former president of the EFLM board. During her time as EFLM president, she set up the EFLM Preanalytics Conference and led various working groups, for example. Most recently, she was managing director of Clinical Hospital Sveti Duh in Zagreb and Department Head of Medical Laboratory Diagnostics.
Šimundić completed her doctorate in 2003 at the Faculty of Pharmacy and Biochemistry of the University of Zagreb, where she is a university professor for laboratory medicine. She has received multiple awards for her research in the areas of preanalytics and quality management.